Federal Circuit Says Invalidity Findings In Drug Patent Case Proper

WASHINGTON, D.C. - A dispute over patents relating to the administration of the chemotherapy cancer drug Taxotere was properly resolved with findings of patent invalidity and unenforceability, the Federal Circuit U.S. Court of Appeals ruled April 9 ( ...read more